Bouhuys, M., Lexmond, W. S., Dijkstra, G., Lobatón, T., Louis, E., Biervliet, S. v., . . . Rheenen, P. v. (2021). Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study): Protocol for a partially randomised patient preference trial.
Citación estilo ChicagoBouhuys, Marleen, Willem S. Lexmond, Gerard Dijkstra, Triana Lobatón, Edouard Louis, Stephanie van Biervliet, Henk Groen, Jordi Guardiola, y Patrick van Rheenen. Efficacy of Anti-TNF Dosing Interval Lengthening in Adolescents and Young Adults With Inflammatory Bowel Disease in Sustained Remission (FREE-study): Protocol for a Partially Randomised Patient Preference Trial. 2021.
Cita MLABouhuys, Marleen, et al. Efficacy of Anti-TNF Dosing Interval Lengthening in Adolescents and Young Adults With Inflammatory Bowel Disease in Sustained Remission (FREE-study): Protocol for a Partially Randomised Patient Preference Trial. 2021.